Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

2(66.7%)

Phase 4

1(33.3%)

3Total

N/A(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05959343Not ApplicableCompleted

Enhanced Recovery After Surgery in Oblique Lumbar Interbody Fusion

Role: collaborator

NCT02440204Not ApplicableCompleted

Optimal Sevoflurane Concentration for Intubation in Combination of Clincal Remifentanil Doses

Role: collaborator

NCT03190603Phase 4Completed

Effects of Nonsteroidal Anti-inflammatory Drug (NSAID) on Inflammatory Lesion of Axial Spondyloarthritis

Role: lead

NCT00982969Completed

The Clinical Utility of QuantiFERON in the Diagnosis of Active Tuberculosis

Role: lead

NCT01038830Completed

QuantiFERON Change During Anti-tuberculosis Medication

Role: lead

NCT00981071Completed

The Time of Positive Conversion of Interferon-γ Releasing Assay After Tuberculosis Exposure

Role: lead

NCT00889759Completed

The Role of High Resolution-Computed Tomography (CT) in Tuberculosis (TB) Outbreak Investigation

Role: lead

NCT00982085Unknown

The Status of Asthma in the Korean Military Personnel

Role: lead

All 8 trials loaded